James Boylan

James Boylan, CEO of Enavate Sciences, is an accomplished health care executive, entrepreneur and innovator with nearly three decades of experience. Mr. Boylan most recently served as President and Head of Investment Banking of SVB Leerink, where he architected and led the transformation of Leerink Swann into an industry-leading health care investment bank that was acquired by SVB Financial in 2019. Across his 12 years at SVB Leerink and prior 12 years as a Managing Director at Merrill Lynch, Mr. Boylan has worked with hundreds of life sciences and biotechnology companies to develop strategy and complete transactions in capital markets and mergers & acquisitions. Mr. Boylan has a broad network of CEO, CFO, board member, venture capital, investor and advisor relationships in the health care field. He brings to Enavate both his wealth of experience in the life sciences sector as well as his skillset in partnering with entrepreneurs to build companies for long-term growth.

Mr. Boylan earned an M.B.A in finance from the Columbia Business School and a B.S. in finance from Lehigh University.